01-05-2001
Plasminogen Activator Inhibitor Type-1 (Part Two): Role for Failure of Thrombolytic Therapy. PAI-1 Resistance as a Potential Benefit for New Fibrinolytic Agents
Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2001
Login to get access